BEOVU 6 mg/.05mL

BEOVU 6 mg/.05mL is an intravitreal injection solution containing brolucizumab. This medication is used to treat certain eye conditions, including wet age-related macular degeneration (AMD). Learn more about brolucizumab and its uses.

BEOVU 6 mg/.05mL is primarily used for the treatment of wet age-related macular degeneration (AMD). This condition affects the macula, the central part of the retina, and can lead to vision loss. Brolucizumab is designed to inhibit vascular endothelial growth factor (VEGF), which plays a role in the abnormal blood vessel growth associated with wet AMD. Patients often wonder, 'What is brolucizumab used for?' and the answer lies in its ability to help manage and slow the progression of this eye disease.

Common effects of BEOVU 6 mg/.05mL may include eye redness, floaters, and increased eye pressure. Some patients may also experience eye pain or discomfort following the injection. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

BEOVU 6 mg/.05mL should be handled with care, as it is intended for intravitreal use only. The medication should be stored and administered under sterile conditions to minimize the risk of infection. Patients should follow their healthcare provider's instructions for post-injection care to ensure the best possible outcomes.

BEOVU 6 mg/.05mL may interact with other medications, particularly those that affect the eyes or immune system. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also interact with brolucizumab, so it's important to discuss any dietary concerns with a healthcare professional.